{"rows":[{"id":5965,"title":"Stroboscopic light stimulation as a controllable probe of the psilocybin state: a mechanistic framework and a falsifiable prediction","authors":"Żełabowski Kacper, Wieczorek Tomasz, Hamed Adam","journal":"Frontiers in Pharmacology","publication_date":"2026-09-30","publication_year":2026,"doi":"10.3389/fphar.2026.1852799","pubmed_id":null,"openalex_id":"https://openalex.org/W7214906093","source_url":"https://doi.org/10.3389/fphar.2026.1852799","substance_tags":"psilocybin,psilocin","topic_tags":"Brain Imaging,Receptor Pharmacology,Consciousness,Aging,Drug Interactions","study_type":"Other","source_name":"Crossref","publication_status":"published","date_added":"2026-10-01 01:20:23","last_checked":"2026-10-07 01:20:24","bibtex":null,"source_record_id":"DOI:10.3389/fphar.2026.1852799","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.3389/fphar.2026.1852799","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"DOI:10.3389/fphar.2026.1852799","source_url":"https://doi.org/10.3389/fphar.2026.1852799","doi":"10.3389/fphar.2026.1852799","pmid":"","publication_date":"2026-09-30","importer_version":"2.1.3","text_redistributed":false}},{"id":4064,"title":"Editorial: Psychedelic substances and neurological diseases: from basics to clinical application","authors":"Alessandra Linardi, Ariadiny Lima Caetano, Rodrigo Portes Ureshino","journal":"Frontiers in Pharmacology","publication_date":"2026-03-15","publication_year":2026,"doi":"10.3389/fphar.2026.1816812","pubmed_id":"41919223","openalex_id":"https://openalex.org/W7136503554","source_url":"https://doi.org/10.3389/fphar.2026.1816812","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,PTSD,Addiction,Neuroplasticity,Pharmacology,Mechanism of Action,Receptor Pharmacology,Consciousness,Mitochondrial Function,Oxidative Stress,Wellbeing,Spirituality,Clinical Trial,Review Article,Animal Study,Toxicity,Proteomics,Inflammation","study_type":"Clinical Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:36","last_checked":"2026-07-04 06:34:36","bibtex":null,"source_record_id":"PMID:41919223","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.3389/fphar.2026.1816812","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"PMID:41919223","source_url":"https://doi.org/10.3389/fphar.2026.1816812","doi":"10.3389/fphar.2026.1816812","pmid":"41919223","publication_date":"2026-03-15","importer_version":"2.1.3","text_redistributed":false}},{"id":1158,"title":"In vitro and in vivo metabolism of psilocybin’s active metabolite psilocin","authors":"Thomann Jan, Kolaczynska Karolina E., Stoeckmann Oliver V., Rudin Deborah, Vizeli Patrick, Hoener Marius C., Pryce Christopher R., Vollenweider Franz X., Liechti Matthias E., Duthaler Urs","journal":"Frontiers in Pharmacology","publication_date":"2024-04-29","publication_year":2024,"doi":"10.3389/fphar.2024.1391689","pubmed_id":"38741590","openalex_id":"https://openalex.org/W4396224564","source_url":"https://doi.org/10.3389/fphar.2024.1391689","substance_tags":"psilocybin,psilocin","topic_tags":"Pharmacology,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Animal Study,In Vitro Study,Drug Interactions","study_type":"Clinical Trial","source_name":"Crossref","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:49","bibtex":null,"source_record_id":"PMID:38741590","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.3389/fphar.2024.1391689","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"PMID:38741590","source_url":"https://doi.org/10.3389/fphar.2024.1391689","doi":"10.3389/fphar.2024.1391689","pmid":"38741590","publication_date":"2024-04-29","importer_version":"2.1.3","text_redistributed":false}}],"total":3,"page":1,"per_page":20,"pages":1,"resource":"papers","filters":{"q":null,"author":null,"substances":["psilocybin","psilocin"],"topic":null,"study_type":null,"cited_doi":null,"sources":[],"publication_statuses":[],"year":null,"journal":"Frontiers in Pharmacology","from":null,"to":null,"added_from":null,"added_to":null,"sort":"newly_added","page":1,"per_page":"20"}}